Problems in assessment of new pharmacologic agents for the heart failure patient
- 30 September 1981
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 102 (3) , 584-590
- https://doi.org/10.1016/0002-8703(81)90748-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Oral amrinone in refractory congestive heart failureThe American Journal of Cardiology, 1980
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- Nitrate therapy of heart failure in valvular heart diseaseThe American Journal of Medicine, 1978
- Vasodilator Therapy — A Physiologic Approach to the Treatment of Heart FailureNew England Journal of Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.Circulation Research, 1976
- Dopamine — Clinical Uses of an Endogenous CatecholamineNew England Journal of Medicine, 1974
- IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1972